Biotech unicorn Moderna raises another $125M from partner Merck
May 03, 2018 at 17:48 PM EDT
The privately held Cambridge biotech is valued at $7 billion, making it a rare unicorn in the Massachusetts life sciences industry.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|